Mary Stofan

Rutgers, The State University of New Jersey

Also affiliated with Environmental and Occupational Health Sciences Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Bile Acids and FXR: Novel Targets for Liver Diseases”.

Bile Acids and FXR: Novel Targets for Liver Diseases

Frontiers in Medicine(2020)10.3389/fmed.2020.00544

N/A

0DataRank · unranked

201 citations

Grace L. Guo, Mary Stofan

Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR

eGastroenterology(2025)10.1136/egastro-2025-100227

N/A

0DataRank · unranked

3 citations

Syeda Maliha, Veronia Basaly, Zhenning Yang, Rulaiha Taylor, Katherine Otersen +13 more

Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice

Drug Metabolism and Disposition(2025)10.1016/j.dmd.2025.100128

N/A

0DataRank · unranked

0 citations

Mary Stofan, Bo Kong, Rulaiha Taylor, Zakiyah Henry, Syeda Maliha +3 more